1300031-61-1

Basic information

• Product Name: [3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine
• Synonyms: [3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine;3-(3,5-dimethylisoxazol-4-yl)-4-methoxyaniline
• CAS NO: 1300031-61-1
• Molecular Formula: C₁₂H₁₄N₂O₂
• Molecular Weight: 218.25176
• Mol File: 1300031-61-1.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 343.3±42.0 °C(Predicted)
• Appearance: /
• Density: 1.151±0.06 g/cm3(Predicted)
• PKA: 4.55±0.10(Predicted)
• CAS DataBase Reference: [3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine(1300031-61-1)
• EPA Substance Registry System: [3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine(1300031-61-1)

Safety Data

• Hazardous Substances Data: 1300031-61-1(Hazardous Substances Data)

Usage

General Description

The chemical "[3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine" is an amine compound that contains a substituted isoxazolyl ring and a methyloxyphenyl group. It is a derivative of the phenylamine class of compounds. The presence of the isoxazolyl and methyloxy groups contributes to its unique chemical and biological properties. [3-(3,5-diMethyl-4-isoxazolyl)-4-(Methyloxy)phenyl]aMine may have potential applications in various fields such as pharmaceuticals, agrochemicals, and materials science. Its precise properties and uses would depend on further research and development.

Upstream product

• 832114-00-8 3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole 
• 74587-12-5 3-iodo-4-methoxyaniline 
• 10558-25-5 4-bromo-3,5-dimethyl-1,2-oxazole 
• 1300031-62-2 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole 
• 5399-03-1 2-iodo-1-methoxy-4-nitrobenzene 
• 16114-47-9 3,5-dimethylisoxazole-4-boronic acid 

Downstream Products

• 1300031-60-0 1,3-diethyl 2-([[3-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methoxyphenyl]amino]methylidene)propanedioate 
• 1300031-49-5 I-BET151 
• 1300031-57-5 4-chloro-7-(3,5-dimethyl-4-isoxazolyl)-6-(methyloxy)-3-quinolinecarboxamide 
• 1300737-57-8 Ethyl 4-{[2-(1,1-di methylethyl)phenyl]amino}-7-(3,5-dimethyl-4-isoxazolyl)-6-(methoxy)-3-quinolinecarboxylate 
• 1300737-63-6 4-{[2-(1,1-dimethylethyl)phenyl]amino}-7-(3,5-dimethyl-4-isoxazolyl)-6-(methoxy)-3-quinolinecarboxylic acid hydrochloride 
• 1300737-69-2 7-(3,5-dimethyl-4-isoxazolyl)-6-(methyloxy)-4-{[(1R)-1-(2-pyridinyl)ethyl]amino}-3-quinolinecarboxamide 

Relevant articles and documents

METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE

The present disclosure relates to compounds and methods for modulating the expression of dmpk, and treating diseases and conditions in which dmpk plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.

OXAZOLO[5,4-C]QUINOLIN-2-ONE COMPOUNDS AS BROMODOMAIN INHIBITORS

The present invention relates to compounds useful as bromodomain inhibitors. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compounds and compositions in the treatment of various diseases and disorders.

4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR

Novel quinoline compounds of formula (I), pharmaceutical compositions containing such compounds and their use in therapy, as bromodomain inhibitors.